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ABSTRACT 
Cancer nanotherapeutics is beginning to overwhelm the global research and viewed to be the 
revolutionary treatment regime in the medical field. This investigation describes the 
development of a stable nanostructured lipid carrier (NLC) system as carrier for Tamoxifen 
(TAM). The TAM-loaded NLC (TAM-NLC) developed with 200 mg of TAM showed a 
spherical particle with the size of 46.6 nm, polydispersity index of 0.267, entrapment 
efficiency of 99.74% and with the zeta potential of -23.78 mV. Besides, the equivalent 
cytotoxicity of TAM and TAM-NLC to human (MCF-7) and mice (4T1) mammary breast 
cancer cell lines were observed. Incubating the formulation at the physiological pH resulted 
into reduced Ostwald ripening rate but without any significant change in the absorptivity. 
When coupled with the measurements of zeta potential and Ostwald ripening rate, the 
absorbance assay may be used to predict the long-term stability of drug-loaded nanoparticle 
formulations. The results of the study also suggest that TAM-NLC is a promising drug 
delivery system for breast cancer therapy. This is the first encouraging report on the in vitro 
effect of TAM-NLC against human and mouse mammary adenocarcinoma cell lines. 
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